Dalian Allychem Chemical Co., Ltd. (www.allychem.com) is an outward-oriented technology enterprise established in 2004 by overseas returnees with rich experience in international new drug development and modern business management, with a registered capital of 66 million yuan. The company is dedicated to the research, production, and sales of advanced pharmaceutical intermediates, boric acid ester series products represented by bis(pinacolato)diboron, chiral auxiliaries represented by tert-butyl sulfinamide, and custom-made products. The company boasts well-equipped laboratories, modern analytical equipment, multi-functional kilogram-level laboratories, and pilot-scale production workshops. Relying on high-quality products and excellent customer service, it widely serves global pharmaceutical companies and biotechnology, agrochemical, and specialty chemical companies, covering FTE project research, small molecule compound synthesis, chemical process research and development, as well as production at scales from kilograms to tons. Currently, through independent research and development, the company has mastered proprietary industrial synthesis technologies for a series of chiral intermediates, chiral auxiliaries, and coupling reagents, having developed dozens of industrialized products across two series: chiral chemistry and boron chemistry, and holds over 10 Chinese invention patents. The company's products are sold to hundreds of companies both domestically and in Europe, America, Japan, and other regions. To meet customer needs, achieve long-term development, and enhance corporate competitiveness, Dalian Allychem Pharmaceutical Technology Co., Ltd., focusing on the R&D field, was established in 2006 as an outward-oriented technology enterprise, which has been tracking the latest market demands internationally since its establishment. The industrialization base of Dalian Allychem Chemical Co., Ltd. started construction in April 2008 and officially came into use in 2009. This industrialization project was selected for funding under the national development and reform commission’s 2008 treasury bond program. In June 2009, Allychem USA was founded in New Jersey, known as "America's Medicine Valley," where high-level international pharmaceutical chemistry experts were hired to join, further enhancing the R&D level and international market competitiveness of Allychem. The company has established a complete quality control system to ensure product quality stability, earning trust and positive feedback from customers. In October 2009, the company fully passed the ISO9001 international quality system certification. Since its establishment, the company has always paid great attention to the health of its employees, especially the occupational health of technical personnel, and has set up occupational health records for employees. Allychem adheres to the core values of "integrity, diligence, cooperation, and innovation," gathering a high-quality professional team in research, management, production, and marketing. The decision-making level of the company is keen-minded, forward-thinking, highly professionally qualified, and experienced in business management. Over 40% of the company's staff are R&D personnel, most of whom hold doctoral or master's degrees. Relying on technological innovation, Dalian Allychem Chemical Co., Ltd. actively builds a modern enterprise management model, aiming to become a leading star enterprise in the domestic pharmaceutical intermediate and fine chemical industry.